Recent Finacing
Recent Raise
Emergo Therapeutics develops norketotifen, the active metabolite of ketotifen, as a therapeutic to modulate immune responses to viral infections and reduce flu-like symptoms, advancing development and testing.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Emergo Therapeutics.
